e-learning
resources
ERJ
2016
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
99mTc-anti-TNF-alpha antibody for the imaging of disease activity in pulmonary sarcoidosis
Vis Roeland, Malviya Gaurav, Signore Alberto, Grutters Jan C., Meek Bob, van de Garde Ewoudt M.W., Keijsers Ruth G.M.
Source:
Eur Respir J 2016; 47: 1198-1207
Journal Issue:
April
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Vis Roeland, Malviya Gaurav, Signore Alberto, Grutters Jan C., Meek Bob, van de Garde Ewoudt M.W., Keijsers Ruth G.M.. 99mTc-anti-TNF-alpha antibody for the imaging of disease activity in pulmonary sarcoidosis. Eur Respir J 2016; 47: 1198-1207
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pulmonary sarcoidosis
Definition and history of sarcoidosis
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Antielastin antibodies in chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012
Utility of myositis related antibodies in interstitial lung disease and suspected autoimmunity.
Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Year: 2019
Anti-elastin autoantibodies are not present in combined pulmonary fibrosis and emphysema
Source: Eur Respir J 2009; 33: 219-221
Year: 2009
Detection of various autoantibodies in patients with pulmonary sarcoidosis
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019
Serum anti DFS70 antibody titer and lung functional impairment in patients with interstitial lung disease (ILD)
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017
Clinical features and CT findings of anti-Jo-1 antibody positive interstitial lung disease with or without polymyositis and dermatomyositis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013
Pulmonary manifestations of immunoglobulin G4-related sclerosing disease
Source: Eur Respir J 2012; 39: 180-186
Year: 2012
Pulmonary manifestations of immunoglobulin G4-related sclerosing disease
Source: Eur Respir J 2011; 39: 180-186
Year: 2012
The Dutch hypothesis, implications for treatment of chronic obstructive pulmonary disease and asthma in a biomarker, monoclonal antibody world. Experience with IgE and omalizumab in a small pulmonary practice
Source: Annual Congress 2011 - Airways disease comorbidities and general aspects
Year: 2011
Functional imaging of disease activity in sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 266s
Year: 2002
Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension
Source: Eur Respir J 2006 Oct 01;28(4):799-807
Year: 2006
Detection of antibody response against influenza vaccine in patients with chronic obstructive pulmonary disease (COPD) by quantitative ELISA and evalution of clinical findings
Source: Annual Congress 2009 - Viruses and respiratory infections: prevalence and mechanisms of infection
Year: 2009
Oxygen-enhanced MRI of the lung in the assessment of chronic obstructive pulmonary disease
Source: Annual Congress 2006 - New modalities and application in imaging of the chest
Year: 2006
Circulating auto antibodies in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Pathophysiology of COPD
Year: 2008
The Value of 18F-FDG PET/CT in evaluating disease severity in idiopathic pulmonary fibrosis
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017
CT imaging manifestations of pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 847s
Year: 2006
CT imaging manifestations of pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 428s
Year: 2004
CT imaging manifestations of pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 248s
Year: 2003
Pulmonary ANCA-associated vasculitis mimicking a lung tumour or diffuse lung metastases (with positive PET-CT scan)
Source: International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon
Year: 2018
Change of lung function in severe eosinophilic asthma undergoing treatment with anti-interleukin-5 monoclonal antibody
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept